skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines deucravacitinibQuestion & answer

deucravacitinib · Medicine question

What is Sotyktu (deucravacitinib) approved to treat in adults?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Sotyktu (deucravacitinib) is indicated to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

Sources for this answer

SOTYKTU 6 mg film coated tabletsBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated 9 August 2024

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about deucravacitinib

How much sodium does each Sotyktu (deucravacitinib) tablet contain?What do Sotyktu (deucravacitinib) 6 mg film-coated tablets look like?Does deucravacitinib meaningfully affect exposure to oral contraceptives containing norethindrone acetate and ethinyl estradiol?How does deucravacitinib work?Is it known whether deucravacitinib passes into human breast milk?What does the prescribing information say about deucravacitinib use during pregnancy?

deucravacitinib

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the deucravacitinib guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX